320 related articles for article (PubMed ID: 779855)
21. Lithium: clinical effects and cerebrospinal fluid acid monoamine metabolites.
Bowers MB; Heninger GR
Commun Psychopharmacol; 1977; 1(2):135-45. PubMed ID: 603996
[No Abstract] [Full Text] [Related]
22. Treatment of depression in bipolar disorder: new directions for research.
Zornberg GL; Pope HG
J Clin Psychopharmacol; 1993 Dec; 13(6):397-408. PubMed ID: 8120153
[TBL] [Abstract][Full Text] [Related]
23. [MAO-(monoamine oxidase-)inhibitor plus lithium. 1. Choice in psychopathologic rapidly changing bipolar manic-depressive patients (rapid cyclers)].
Rogan M; Lesch OM; Schjerve M; Musalek M; Walter H
Wien Klin Wochenschr; 1983 Jul; 95(14):498-502. PubMed ID: 6636782
[TBL] [Abstract][Full Text] [Related]
24. [The clomipramine-lithium combination: controlled trial].
Nick J; Luaute JP; Des Lauriers A; Moinet A; Monfort J
Encephale; 1976; 2(1):5-16. PubMed ID: 770150
[TBL] [Abstract][Full Text] [Related]
25. Lithium carbonate prophylaxis of depression in three subtypes in primary affective disorder.
Fieve RR; Dunner DL; Kumbaraci T; Stallone F
Pharmakopsychiatr Neuropsychopharmakol; 1976 May; 9(3):100-7. PubMed ID: 981326
[TBL] [Abstract][Full Text] [Related]
26. Tryptophan in the treatment of depression.
Young SN; Chouinard G; Annable L
Adv Exp Med Biol; 1981; 133():727-37. PubMed ID: 6459010
[No Abstract] [Full Text] [Related]
27. To the antidepressive properties of lithium and its place in the group of antidepressive drugs.
Náhunek K; Svestka J; Rodová A
Act Nerv Super (Praha); 1971; 13(3):169-70. PubMed ID: 4939828
[No Abstract] [Full Text] [Related]
28. [Depression and sleep (author's transl)].
Passouant P
Encephale; 1979; 5(5 Suppl):533-45. PubMed ID: 44863
[TBL] [Abstract][Full Text] [Related]
29. Current concepts in clinical therapeutics: major affective disorders, Part 1.
Bryant SG; Brown CS
Clin Pharm; 1986 Apr; 5(4):304-18. PubMed ID: 3519059
[TBL] [Abstract][Full Text] [Related]
30. Two cases of hypomania following the addition of L-tryptophan to a monoamine oxidase inhibitor.
Goff DC
Am J Psychiatry; 1985 Dec; 142(12):1487-8. PubMed ID: 4073318
[TBL] [Abstract][Full Text] [Related]
31. Lithium studies and manic-depressive illness.
Fieve RR
Proc Annu Meet Am Psychopathol Assoc; 1972; 60():135-50. PubMed ID: 4333975
[No Abstract] [Full Text] [Related]
32. [Indoleamine precursors in depression (author's transl)].
Coppen A; Wood K
Encephale; 1979; 5(5 Suppl):627-32. PubMed ID: 95009
[TBL] [Abstract][Full Text] [Related]
33. Potentiation of a monoamine oxidase inhibitor by tryptophan.
Glassman AH; Platman SR
J Psychiatr Res; 1969 Dec; 7(2):83-8. PubMed ID: 4917709
[No Abstract] [Full Text] [Related]
34. [Therapeutically resistant depressive states].
Aksenova IO
Zh Nevropatol Psikhiatr Im S S Korsakova; 1979; 79(4):473-87. PubMed ID: 375644
[No Abstract] [Full Text] [Related]
35. Lithium carbonate and L-tryptophan in the treatment of bipolar and schizoaffective disorders.
Brewerton TD; Reus VI
Am J Psychiatry; 1983 Jun; 140(6):757-60. PubMed ID: 6405638
[TBL] [Abstract][Full Text] [Related]
36. Evaluation of the combination of tryptophan and ECT in the treatment of depression. I. Clinical analysis.
D'Elia G; Lehmann J; Raotma H
Acta Psychiatr Scand; 1977 Oct; 56(4):303-18. PubMed ID: 335790
[TBL] [Abstract][Full Text] [Related]
37. Choice of antidepressants.
Priest RG
Practitioner; 1977 Oct; 219(1312):487-90. PubMed ID: 594010
[No Abstract] [Full Text] [Related]
38. Neurochemical and neuropharmacological aspects of depression.
Leonard BE
Int Rev Neurobiol; 1975; 18():357-87. PubMed ID: 1354
[No Abstract] [Full Text] [Related]
39. Affective disorder: studies with amine precursors.
Dunner DL; Fieve RR
Am J Psychiatry; 1975 Feb; 132(2):180-3. PubMed ID: 1089363
[TBL] [Abstract][Full Text] [Related]
40. [Biochemistry of depression. Literature analysis].
Moussaoui D
Encephale; 1978; 4(3):193-222. PubMed ID: 30616
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
